| Financial Year |
March 31 2023 |
| Monetary Funds |
3,114,150,381.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
44,454,839.33 |
| Accounts Receivable |
2,965,992,921.28 |
| Advances to Suppliers |
38,493,417.15 |
| Other Receivables |
586,983,271.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,126,252,475.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
52,973,607.28 |
| Other Current Assets |
177,622,439.21 |
| Total Current Assets |
9,233,857,132.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
479,978,966.43 |
| Investment Properties |
321,247,651.84 |
| Fixed Assetes |
3,908,298,180.93 |
| Under-construction Projects |
796,893,926.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
913,800,894.36 |
| R&D expenses |
155,107,211.95 |
| Goodwill |
122,270,674.27 |
| Long-Term Deferred and Prepaid Expenses |
136,322,789.36 |
| Deferred Income Tax Assets |
222,871,328.84 |
| Other Non-Current Assets |
20,265,766.68 |
| Sub-Total of Non-Current Assets |
7,885,983,299.76 |
| Total Assets |
17,119,840,431.91 |
| Short-Term Loans |
2,799,166,931.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
387,798,078.26 |
| Accounts Payable |
4,040,084,844.30 |
| Accounts Received In Advance |
9,168,712.45 |
| Employee Compensation Payable |
308,570,119.84 |
| Taxes Payable |
51,153,826.52 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,390,553.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,379,192,037.56 |
| Other Current Liabilities |
63,139,712.78 |
| Sub-Total of Current Liabilities |
11,236,657,836.73 |
| Long-term Loans |
1,588,487,755.53 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
362,425.03 |
| Special Payable |
-- |
| Estimatied Liabilities |
264,987,986.93 |
| Deferred Income Tax Liabilities |
102,479,516.25 |
| Other Non-Current Liabilities |
575,024.05 |
| Sub-Total of Non-Current Liabilities |
2,313,645,601.08 |
| Total Liabilities |
13,550,303,437.81 |
| Paid-In Capital(Or Share Stock) |
3,257,817,490.00 |
| Capital Surplus |
6,514,026,241.47 |
| Surplus Reserve |
351,004,362.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-7,223,018,869.37 |
| Minority Stockholder's Interest |
681,992,917.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,887,544,076.99 |
| Owner's Equity（Stockholder's Equity） |
3,569,536,994.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,119,840,431.91 |
